A Community-based Resilience Group Psychotherapy for Only-child Loss Parents in China

An 8-week Resilience-based Community Group Intervention Program for Parents Who Have Lost an Only Child in China

Two communities in Changsha was selected, where principle investigators' institution located, to recruit 80 participants into intervention group and control group. Resilience therapy group was intervened by a psychotherapy developed by the researchers, which lasts 8 weeks. The themes of each week are start-up, mutual help, trust in yourself, thanksgiving feedback, care for yourself, emotional management, end-up. Measurement was conducted before the intervention, immediately after intervention, 3-month after intervention, and 12-month after intervention. A questionnaire was used during each measurement, including several scales in it, including resilience and depression.The saliva test of Dehydroepiandrosterone was also done in each measurement.

Study Overview

• Status: Completed
• Conditions: Depression
• Intervention / Treatment: Behavioral: 8-week Resilience Group Psychotherapy; Other: Usual care

• Study Type: Interventional
• Enrollment (Actual): 80
• Phase: Not Applicable

Contacts and Locations

Study Locations

• China
  • Hunan
    • Changsha, Hunan, China, 410013
      • Central South University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 49 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. had only one child but now passed away;
2. failed to have another children;
3. volunteered to participate;
4. the score of resilience was under 72 points indicating a lower or middle level

Exclusion Criteria:

1. in the acute bereavement period (<6 months);
2. unable to participate in activities due to severe physical illness;
3. receiving drug treatment for mental illness;
4. receiving other psychological therapy

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Resilience group	Behavioral: 8-week Resilience Group Psychotherapy; Resilience Group Psychotherapy was intervened by a psychotherapy developed by the researchers. The resilience promotion therapy lasts 8 weeks, and also has a group intervention in each week. The themes of each week are start-up, mutual help, trust in yourself, thanksgiving feedback, care for yourself, emotional management, end-up.
Active Comparator: Controlled group	Other: Usual care; Usual care means treating as usual, such as regular home visit.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change of resilience	A kind of ability to bounce back from adversity measured by Connor-Davidson Resilience Scale, with higher score reflecting higher level of resilience, ranging from 0-100.	Change from before intervention, immediately after intervention,3-month after intervention, to 12-month after intervention
Change of depression	Depressive mood in recent two weeks measured by Zung Self-rated Depression Scale, with higher score reflecting higher level of depression, ranging from 0-80.	Change from before intervention, immediately after intervention,3-month after intervention, to 12-month after intervention.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change of subjective well-being	A feeling of happiness measured by Campbell Index of well-being, with higher score reflecting higher subjective well-being, ranging from 1.1 to 14.7.	Change from before intervention, immediately after intervention,3-month after intervention, to 12-month after intervention.
Change of social avoidance	The phenomenon that a person is absent from normal social interaction with others measured by Social Avoidance and Distress Scale, with higher score reflecting higher social avoidance, ranging from 0 to 7.	Change from before intervention, immediately after intervention,3-month after intervention, to 12-month after intervention.
Change of sleeping quality	Sleep quality in recent month measured by Pittsburgh sleep quality index, with higher score reflecting bad quality, ranging from 0 to 23.	Change from before intervention, immediately after intervention,3-month after intervention, to 12-month after intervention.
Change of post traumatic growth	The positive growth after an adversity measured by Post Traumatic Growth Inventory, with higher score reflecting higher growth, ranging from 20 to 120.	Change from before intervention, immediately after intervention,3-month after intervention, to 12-month after intervention.
Change of concentration of dehydroepiandrosterone in saliva	A kind of hormone that reflects the person's psychological stress collected by saliva collection tube by chewing the sterile cotton strips for 60 seconds, with higher concentration reflecting higher dehydroepiandrosterone level. The unit is pg/ml.	Change from before intervention, immediately after intervention,3-month after intervention, to 12-month after intervention.

Collaborators and Investigators

• Sponsor: Central South University

Study record dates

Study Major Dates

• Study Start (Actual): November 1, 2017
• Primary Completion (Actual): January 30, 2018
• Study Completion (Actual): January 30, 2019

Study Registration Dates

• First Submitted: May 27, 2022
• First Submitted That Met QC Criteria: June 6, 2022
• First Posted (Actual): June 8, 2022

Study Record Updates

• Last Update Posted (Actual): June 8, 2022
• Last Update Submitted That Met QC Criteria: June 6, 2022
• Last Verified: June 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Behavioral Symptoms; Depression
• Other Study ID Numbers: Resilience Group Psychotherapy

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No